NovaBridge Biosciences (NBP) Cash from Investing Activities (2019 - 2025)

NovaBridge Biosciences (NBP) has 3 years of Cash from Investing Activities data on file, last reported at $105.0 million in Q4 2025.

• Cash from Investing Activities for Q4 2025 came in at $105.0 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $105.0 million (up 416.1% YoY), and the FY2025 annual result was $105.0 million, up 570.93% from the prior year.
• Cash from Investing Activities improved to $105.0 million in Q4 2025 per NBP's latest filing, from $8.2 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $105.0 million in Q4 2025 and troughed at $105.0 million in Q4 2025.